Medplus Health Services' shares have been on an upward trend for the past four sessions, trading at Rs 715, which represents a 1.5 percent increase on the NSE.
The stock has gained momentum in the last week, rising 6 percent after a significant Rs 552-crore block deal.
In its most recent quarterly report, Medplus Health announced a remarkable twofold increase in net profit, driven by strong demand for over-the-counter (OTC) medicines.
The company reported a consolidated net profit of Rs 38.74 crore for the second quarter, a substantial rise from Rs 14.56 crore in the same period last year.